Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Beta adrenergic blockade and decompensated cirrhosis

(2017) Thomas Reiberger et al.   JOURNAL OF HEPATOLOGY

Liver sinusoidal endothelial cells: Physiology and role in liver diseases

(2017) Johanne Poisson et al.   JOURNAL OF HEPATOLOGY

Mechanisms of hepatic stellate cell activation

(2017) Takuma Tsuchida et al.   Nature Reviews Gastroenterology & Hepatology

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

(2017) Thomas Reiberger et al.   WIENER KLINISCHE WOCHENSCHRIFT

Angiocrine signaling in the hepatic sinusoids in health and disease

(2016) Enis Kostallari et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Prognostic value of C-reactive protein in cirrhosis

(2016) Jean-Paul Cervoni et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

(2016) Juan G. Abraldes et al.   GASTROENTEROLOGY

Antibiotic prophylaxis in cirrhosis: Good and bad

(2016) Javier Fernández et al.   HEPATOLOGY

von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia

(2016) Georgios N. Kalambokis et al.   JOURNAL OF HEPATOLOGY

Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments

(2015) Jaume Bosch et al.   JOURNAL OF HEPATOLOGY

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites

(2015) Philipp Schwabl et al.   LIVER INTERNATIONAL

Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient

(2015) Arnulf Ferlitsch et al.   LIVER INTERNATIONAL

Prognostic value of C-reactive protein levels in patients with cirrhosis

(2015) Vincent Di Martino et al.   LIVER TRANSPLANTATION

A gut-vascular barrier controls the systemic dissemination of bacteria

(2015) Ilaria Spadoni et al.   SCIENCE

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

(2014) Mattias Mandorfer et al.   GASTROENTEROLOGY

KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins

(2014) Giusi Marrone et al.   GUT

Inflammation and portal hypertension – The undiscovered country

(2014) Gautam Mehta et al.   JOURNAL OF HEPATOLOGY

Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

(2014) Rajiv Jalan et al.   JOURNAL OF HEPATOLOGY

Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

(2013) A. Maieron et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis

(2013) Armando Tripodi et al.   JOURNAL OF HEPATOLOGY

The burden of liver disease in Europe: A review of available epidemiological data

(2013) Martin Blachier et al.   JOURNAL OF HEPATOLOGY

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

(2012) Erica Villa et al.   GASTROENTEROLOGY

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

(2012) Monika Ferlitsch et al.   HEPATOLOGY

C-Reactive protein predicts short-term mortality in patients with cirrhosis

(2012) Jean-Paul Cervoni et al.   JOURNAL OF HEPATOLOGY

The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins

(2012) Giusi Marrone et al.   JOURNAL OF HEPATOLOGY

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

(2012) Thomas Reiberger et al.   JOURNAL OF HEPATOLOGY

Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension

(2011) V. La Mura et al.   GUT

Spontaneous bacterial peritonitis: recent guidelines and beyond

(2011) R Wiest et al.   GUT

The Coagulopathy of Chronic Liver Disease

(2011) Armando Tripodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis

(2010) Pablo Bellot et al.   HEPATOLOGY

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method

(2010) Armando Tripodi et al.   HEPATOLOGY

An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis

(2009) Armando Tripodi et al.   GASTROENTEROLOGY

Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial

(2009) Juan G. Abraldes et al.   GASTROENTEROLOGY